Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 4176 - 4200 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula
Gangliosides LMSP0601AT02
  • GT1b(d18:1/18:0)
  • NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262117 60913 2128.0675 C95H165N5O47
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AQ02
  • GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • type II A antigen(d18:1/18:0)
44261101 1969.050726 C90H160N4O42
Simple Glc series LMSP05010104
  • Catacerebroside A
  • N-(2R-hydroxy-17Z-tetracosenoyl)-1-beta-glucosyl-9-methyl-sphing-4E,8E-dienine
10930878 837.669384 C49H91NO9
LMSL03000688
  • 2-octadecanoyl-3-O-(2,4S,6S-trimethyl-2E-docosenoyl)-6-O-(2,4S,6S-trimethyl-2E-tetracosenoyl)-2'-O-(2,4S,6S-trimethyl-2E-hexacosenoyl)-4'-O-(2,4S,6S-trimethyl-2E-tetracosenoyl)-alpha,alpha-trehalose
  • PAT18(22:1(2E)(2Me,4Me[S],6Me[S])/24:1(2E)(2Me,4Me[S],6Me[S])/26:1(2E)(2Me,4Me[S],6Me[S])/24:1(2E)(2Me,4Me[S],6Me[S]))
52930525 2169.92184 C138H256O16
Ascarosides LMFA13040082
  • 3R-hydroxy-13-(3,6-dideoxy-alpha-L-arabino-hexopyranosyloxy)-tridecanoic acid
  • bhos#22
86289849 79261 376.246105 C19H36O7
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AA01
  • Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • Gb3(d18:1/16:0)
44260164 84687 1023.670569 C52H97NO18
Gangliosides LMSP0601DX06
  • NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Fucalpha1-3GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262729 2153.197056 C101H180N4O44
Diacylglycerophosphoinositolglycans LMGP15010166
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(18:1(9Z)/16:1(9Z))
126457534 1482.737133 C67H119O33P
Diacylglycerophosphoinositolglycans LMGP15010160
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-octadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(18:0/16:1(9Z))
126457528 1484.752783 C67H121O33P
Gangliosides LMSP0601AH05
  • NeuAcalpha2-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262024 1629.970562 C79H143N3O31
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AO02
  • GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261925 1457.860617 C70H127N3O28
Simple Glc series LMSP05010174
  • N-(2R-hydroxy-17Z-hexacosenoyl)-1-beta-D-glucosyl-sphing-4E,8E,10E-trienine
  • Renieroside A2
23643434 849.669384 C50H91NO9
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AG07
  • Galbeta1-3(Galbeta1-4GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260218 1864.044517 C88H157N3O38
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BX07
  • Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261370 2594.308915 C116H203N5O58
LMSL03000462
  • 2-O-hexadecanoyl-3-O-(2,4S,6S-trimethyl-2E-hexacosenoyl)-6-O-(2,4S,6S-trimethyl-2E-pentacosenoyl)-2'-O-(2,4S,6S-trimethyl-2E-hexacosenoyl)-4'-O-(2,4S,6S-trimethyl-2E-docosenoyl)-alpha,alpha-trehalose
  • PAT16(26:1(2E)(2Me,4Me[S],6Me[S])/25:1(2E)(2Me,4Me[S],6Me[S])/26:1(2E)(2Me,4Me[S],6Me[S])/22:1(2E)(2Me,4Me[S],6Me[S]))
52930299 2183.93749 C139H258O16
Diacylglycerophosphoinositolglycans LMGP15010063
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-octadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(18:0/16:0)
126457431 1162.662783 C55H103O23P
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC02
  • Forssman antigen(d18:1/18:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260181 1457.860617 C70H127N3O28
Glycosylmonoacylglycerols LMGL04010009
  • 1-(7Z,10Z,13Z-hexadecatrienoyl)-3-O-beta-D-galactosyl-sn-glycerol
  • MGMG(16:3(7Z,10Z,13Z)/0:0)
102119785 486.282885 C25H42O9
Gangliosides LMSP0601FB00
  • NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer
GSG1131
Gangliosides LMSP0601BY03
  • NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262366 1589.902877 C75H135N3O32
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AQ08
  • Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • Isoglobotriglycosylceramide(d18:1/26:1(17Z))
44261571 1161.811419 C62H115NO18
Glycosyldiacylglycerols LMGL05010047
  • 1(12-(1'Z,3'Z-hexadienyloxy)-9Z,11E-dodecadienoyl)-2-hexadecanoyl-3-O-beta-D-galactosyl-sn-glycerol
  • Linolipin I
171120440 766.523115 C43H74O11
Diacylglycerophosphoinositolglycans LMGP15010252
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM6(17:0/18:0)
126457620 1824.889733 C80H145O43P
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AK06
  • GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • nLc5Cer(d18:1/26:0)
44261057 1569.985817 C78H143N3O28
Ascarosides LMFA13040016
  • 20R-(3,6-dideoxy-alpha-L-arabino-hexopyranosyloxy)-heneicosanoic acid
  • ascr#38
86289709 78976 472.37639 C27H52O6

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024